-Review of recent scientific articles on the importance of phospholipids in immunity and inflammation. It contributes to a background foundation, helping to explain why CellBB is a game-changer in the world of supplements and wellness-    

Introduction

The immune system depends on healthy cells that can communicate, respond to danger, and destroy threats. In recent years, scientists have learned that lipids, especially phospholipids, play a much larger role in immune function than previously thought. Phospholipids are the main building blocks of cell membranes, but they also act as signaling molecules and energy sources. Changes in phospholipid metabolism can strongly affect how immune cells behave.

Three recent research papers published in 2025 explore how phospholipid metabolism influences innate immunity, with special attention to natural killer (NK) cells. NK cells are a type of immune cell that helps destroy virus‑infected cells and cancer cells. These studies show that when phospholipid balance is disturbed by cancer, autoimmune disease, or inflammation, NK cells can become weak or dysfunctional. Together, these papers help explain how lipid metabolism connects inflammation, immune imbalance, and disease.

Overview of Phospholipids in Innate Immunity

The paper “Phospholipid metabolism in innate immunity and inflammation: from basic to clinic” provides a broad overview of how phospholipids regulate immune responses. Innate immune cells, including macrophages, neutrophils, and NK cells, rely on phospholipids to maintain healthy membranes and to transmit signals within cells.

Phospholipids such as phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine help control membrane fluidity. This affects how receptors move and cluster on the cell surface. When receptors do not function properly, immune cells may fail to activate or may overreact, leading to chronic inflammation.

The paper also explains that phospholipids can be broken down into bioactive lipid mediators, such as prostaglandins and leukotrienes. These molecules help control inflammation by increasing or reducing immune activity. Balanced phospholipid metabolism supports proper immune responses, while imbalances can push the immune system toward long‑term inflammation or immune suppression.

Importantly, the authors highlight that abnormal phospholipid metabolism is not just a side effect of disease—it can actively drive immune dysfunction. This idea sets the stage for understanding NK cell problems seen in cancer and autoimmune disorders.

NK Cell Metabolism and Cancer‑Related Lipid Exposure

The second paper, “Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer,” focuses on NK cell failure in the tumor environment. In ovarian cancer, fluid called ascites accumulates in the abdomen. This fluid is rich in lipids, including phospholipids.

The study shows that NK cells absorb excess lipids from ascites. While NK cells need some lipids for energy and membrane repair, excessive lipid uptake can overwhelm them. The extra phospholipids alter the structure of the NK cell membrane and disrupt mitochondrial function. Mitochondria are the cell’s energy factories, and when they fail, NK cells lose their killing ability.

One key finding is that phosphatidylcholine, when taken up in large amounts, disrupts membrane organization. This prevents NK cells from forming proper immune synapses, which are needed to kill cancer cells. As a result, the NK cells remain alive but become ineffective.

This paper is important because it shows how the tumor environment can metabolically paralyze immune cells without killing them. It also suggests that restoring healthy lipid balance could help reactivate NK cells in cancer therapy.

Phospholipids and Autoimmune‑Related NK Cell Dysfunction

The third paper, “NK cell dysfunction in antiphospholipid syndrome,” examines a very different disease: an autoimmune condition where the body produces antibodies against phospholipids.

In antiphospholipid syndrome (APS), antibodies bind to phospholipids in cell membranes and blood proteins. This causes chronic inflammation, blood clots, and immune imbalance. The study shows that NK cells in APS patients have reduced cytotoxic activity and abnormal signaling.

The researchers link this dysfunction to disrupted phospholipid signaling in NK cell membranes when phospholipids are targeted by antibodies, and to changes in membrane organization that interfere with receptor signaling pathways NK cells use to recognize and destroy abnormal cells.

Unlike cancer, where external lipids overload NK cells, APS causes immune‑driven phospholipid damage. In both cases, however, the result is the same: NK cells lose their effectiveness due to altered membrane and metabolic health.

Shared Mechanisms Across the Three Studies

Although these three papers examine different diseases, they reveal common mechanisms:

1. Phospholipid balance is critical for NK cell function
   NK cells require well‑organized membranes and healthy lipid metabolism to kill target cells.
2. Disrupted lipid environments weaken immunity
   Excess lipids (as in cancer ascites) or immune‑mediated lipid damage (as in APS) both impair NK cells.
3. Mitochondrial health is closely tied to phospholipids
   Changes in phospholipids affect mitochondrial membranes, reducing energy production and immune activity.
4. Immune dysfunction can occur without cell death
   NK cells may survive but become metabolically exhausted or “silent,” allowing disease to progress.

These shared findings support the idea that phospholipid metabolism sits at the center of immune regulation, linking inflammation, cancer, and autoimmunity.

Clinical and Therapeutic Implications

Together, these studies suggest new ways to support immune health. If phospholipid imbalance causes immune dysfunction, then restoring membrane lipid balance could improve immune responses.

Possible therapeutic strategies include:

• Supporting healthy phospholipid turnover
• Protecting membranes from oxidative damage
• Modulating lipid uptake in tumor environments
• Correcting abnormal lipid signaling in autoimmune disease

Rather than targeting immune cells alone, these approaches focus on the metabolic environment that immune cells depend on.

Conclusion

The three 2025 studies reviewed here show that phospholipids are more than simple structural molecules. They actively control immune cell metabolism, signaling, and effectiveness. When phospholipid metabolism is disrupted—by cancer, inflammation, or autoimmunity—NK cells lose their ability to protect the body.

By connecting innate immunity, lipid metabolism, and disease, these papers help explain why immune dysfunction is common in chronic conditions. They also point toward new strategies that restore immune balance by supporting healthy phospholipid function. Understanding and correcting these lipid‑based mechanisms may play an important role in future therapies for cancer, autoimmune disorders, and inflammatory diseases.

 

References:

1.  Liu J. (and co-authors). Phospholipid metabolism in innate immunity and inflammation: from basic to clinic. Immunity & Inflammation, Volume 1, Article 6 (2025). Published online: 29 September 2025. DOI: 10.1007/s44466-025-00001-5 (Open access) Link: https://link.springer.com/article/10.1007/s44466-025-00001-5

2.  Slattery K, Yao CH, Mylod E, Scanlan J, Scott B, Crowley JP, McGowan O, McManus G, Brennan M, O’Brien K, Glennon K, Corry E, Treacy A, Argüello RJ, Gardiner CM, Haigis MC, Brennan DJ, Lynch L. Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer. Science Immunology, 10(107): eadr4795 (2025). Published online: 9 May 2025. DOI: 10.1126/sciimmunol.adr4795 Link: https://www.science.org/doi/10.1126/sciimmunol.adr4795

3.  Martirosyan A. (and co-authors). NK cell dysfunction in antiphospholipid syndrome. Frontiers in Immunology, 16:1593705 (2025). Published online: 12 June 2025. DOI: 10.3389/fimmu.2025.1593705 (Open access) Link: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1593705/fu